MUR
47
2
BRK.B
36
2
APH
53
-6
TRIP
46
3
RHI
27
4
BK
72
-2
MCO
65
9
SEE
52
2
QRVO
42
-4
CMI
68
-3
DE
39
-6
ILMN
44
3
PYPL
41
2
STI
15
5
ORCL
46
-6
ABT
53
-9
SJM
46
3
RIG
29
-3
EMN
52
4
PCG
70
6
MUR
47
2
BRK.B
36
2
APH
53
-6
TRIP
46
3
RHI
27
4
BK
72
-2
MCO
65
9
SEE
52
2
QRVO
42
-4
CMI
68
-3
DE
39
-6
ILMN
44
3
PYPL
41
2
STI
15
5
ORCL
46
-6
ABT
53
-9
SJM
46
3
RIG
29
-3
EMN
52
4
PCG
70
6
Financhill
Back

Biomerica, Inc. 10K Form

Sell
40

BMRA
Biomerica, Inc.

Last Price:
$3.00
Seasonality Move:
16.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-10-12 10Q BMRA/Biomerica, Inc. Quarterly
2023-04-14 10Q BMRA/Biomerica, Inc. Quarterly
2023-01-13 10Q BMRA/Biomerica, Inc. Quarterly
2022-10-13 10Q BMRA/Biomerica, Inc. Quarterly
2022-04-14 10Q BMRA/Biomerica, Inc. Quarterly
2022-01-12 10Q BMRA/Biomerica, Inc. Quarterly

Receive BMRA News And Ratings

See the #1 stock for the next 7 days that we like better than BMRA

BMRA Financial Statistics

Sales & Book Value

Annual Sales: $5.3M
Cash Flow: $-1M
Price / Cash Flow: 0
Annual Sales: $2.17
Price / Book: 1.44

Profitability

EPS (TTM): -2.32000
Net Income (TTM): $-4.9M
Gross Margin: $498K
Return on Equity: -79.79%
Return on Assets: -57.58%

Biomerica, Inc. Earnings Forecast

Key Biomerica, Inc. Financial Ratios

  • The Gross Profit Margin over the past 42 years for BMRA is 9.38%.
  • The Selling, General & Administrative Expenses for BMRA have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 19.26% of Revenue.
  • The Net Earning history of BMRA is -93.64% of Total Revenues.
  • Per Share Earnings over the last 42 years have been positive in 21 years.

Biomerica, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: BMRA
CUSIP: 09061H
Website: biomerica.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.76
Quick Ratio: 2.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BMRA Technical Analysis vs Fundamental Analysis

Sell
40
Biomerica, Inc. (BMRA) is a Sell

Is Biomerica, Inc. a Buy or a Sell?

  • Biomerica, Inc. stock is rated a Sell
    The current Biomerica, Inc. [BMRA] share price is $3.13. The Score for BMRA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.